CD83 and inflammatory bowel disease: The aim of this study is to assess the impact of applied therapy, level of inflammation in biopsy specimens and phenotype of inflammatory bowel diseases on the presence of mucosal mature CD83+ dendritic cell in colonic biopsy samples.